Simplifying regimens promotes greater adherence and outcomes with topical acne medications: A randomized controlled trial

Cutis

Volumn 86, Issue 2, 2010, Pages 103-108

  Yentzer, Brad A ^a   Ade, Rachel A ^a   Fountain, Julie M ^a   Clark, Adele R ^a   Taylor, Sarah L ^a   Fleischer Jr , Alan B ^a   Feldman, Steven R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CLINDAMYCIN; RETINOIC ACID; GEL;

ACNE VULGARIS; ADOLESCENT; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COMBINATION; FEMALE; GEL; HOSPITALIZATION; HUMAN; MALE; NONPARAMETRIC TEST; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME; ADMINISTRATION AND DOSAGE; SEVERITY OF ILLNESS INDEX;

ACNE VULGARIS; ADMINISTRATION, TOPICAL; ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CLINDAMYCIN; DRUG THERAPY, COMBINATION; FEMALE; GELS; HUMANS; MALE; PATIENT COMPLIANCE; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; TRETINOIN;

EID: 77957911029     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Koo J. How do you foster medication adherence for better acne vulgaris management? Skinmed. 2003;2:229-233.
2. Carroll CL, Feldman SR, Camacho FT, et al. Adherence to topical therapy decreases during the course of an 8-week psoriasis clinical trial: commonly used methods of measuring adherence to topical therapy overestimate actual use. J Am Acad Dermatol 2004:51:212-216.
3. Kjcllgrcn KI, Ring L, Lindblad AK, ct al. To follow dcrmatological treatment regimens-patients' and providers' views. Acta Derm Venereol 2004:84:445-450.
4. Witkowski JA. Compliance: the dermatologie patient. Im J Dermatol. 1988;27:608-611.
5. Rietschel RL, Duncan SH. Clindamycin phosphate used in combination with tretinoin in the treatment of acne. Inf J Dermatol. 1983;22:41-43.
6. Thiboutot D, Gollnick H, Bettoli V, et al. New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group. J Am Acad Dermatol. 2009:60(suppl 5):S1-S50.
7. Leyden JJ. A review of the use of combination therapies for the treatment of acne vulgaris. J Am Acad Dermatol. 200.3;49(suppl 3):S200-S210.
8. Richter JR, Förström LR. Kiistala UO. et al. Efficacy of the fixed 1.2% clindamycin phosphate, 0.025% tretinoin gel formulation (Velac) and a proprietary 0.025% tretinoin gel formulation (Aberela) in the topical control of facial acne. J Eur Acad Dermaui Venereal. 1998;11:227-233.
9. Del Rosso JQ, Baldwin H, Keri J, et al. Current approach to acne management: a community-based analysis. Cutis. 2009;83(suppl 6):5-21.
10. Baldwin HE. Tricks for improving compliance with acne therapy. Dermatol Ther. 2006:19:224-236.
11. Berson DS. Shalita AR. The treatment of acne: the role of combination therapies. J Am Acad Dermatol. 1995; 32(5, pt 3):S31-S41.
12. Leyden JJ, Krochmal L, Yaroshinsky A. Two randomized, double-blind, controlled trials of 2219 subjects to compare the combination clindamycin/tretinoin hydrogcl with each agent alone and vehicle for the treatment of acne vulgaris. J Am Acatl Dermatol. 2006;54:73-81.
13. Zaghloul SS, Cunliffe WJ, Goodfield MJ. Objective assessment of compliance with treatments in acne. Br J Dermatol 2005:152:1015-1021.
14. Schroeder K, Fahey T, Ebrahim S. How can we improve adherence to blood pressure-lowering medication in ambulatory care? systematic review of randomized controlled trials. Arch Intern Med. 2004;164:722-732.
15. Eisen SA. Miller DK. Woodward RS, et al. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med. 1990;150:1881-1884.
16. Koehler AM, Maibach HI. Electronic monitoring in medication adherence measurement, implications for dermatology. Am J Clin Dermatol 2001:2:7-12.